ArticleHemaSphere2025

The CD123 antibody-drug conjugate pivekimab sunirine exerts profound activity in preclinical models of pediatric acute lymphoblastic leukemia.

Ben Watts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.